Use the tweezers to pull out a segment of DNA from the hepatitis B virus. A subunit vaccine makes use of just a small portion of a pathogen. For a virus, the vaccine can contain just a piece of ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

AS the global health community rallies to eliminate hepatitis B virus (HBV) and hepatitis C virus ... Displaced populations are often stripped of basic rights, clean water, and adequate healthcare ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.